Skip to main content
SpringerLink
Log in

Expression of CD44 Isoforms in Infiltrating Lobular Carcinoma of the Breast

  • Conference Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Expression of CD44 has been shown to correlate with the progression and prognosis of some malignant tumors. The aim of this study was to evaluate the expression of CD44 isoforms in infiltrating lobular carcinomas and analyse their potential as prognostic indicators. A panel of 39 tumors were examined for their expression of membranous and cytoplasmic CD44s, v3, v5, v6, v7 and v3-10 in the infiltrating cells, by immunohistochemical staining. The protein positive tumors showed membranous and/or cytoplasmic staining with all antibodies used except for CD44v7, which only displayed cytoplasmic staining. Cytoplasmic expression of CD44v3 (P=0.014) and membranous expression of v6 (P=0.039) were significantly associated with alveolar, classical/alveolar carcinomas and mucinous/alveolar carcinomas. Furthermore, in alveolar, classical/alveolar and mucinous/alveolar carcinomas, cytoplasmic staining of CD44v5 was correlated with lymph node negative patients (P=0.048), whereas membranous v5 was correlated with lymph positive patients (P=0.048). In classical, classical/trabecular and trabecular carcinomas expression of membranous CD44s was significantly correlated with lymph node status (P=0.042).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thomas L, Byers HR, Vink J, Stamenkovic I: CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118: 971-977, 1992

    Google Scholar 

  2. Spicer AP, Roller ML, Camper SA, McPherson JD, Wasmuth JJ, Hakim S, Wang C, Turley EA, McDonald JA: The human and mouse receptors for hyaluronan-mediated motility, RHAMM, genes (HMMR) map to human chromosome 5q33.2-qter and mouse chromosome 11. Genomics 30: 115-117, 1995

    Google Scholar 

  3. Ruiz P, Schwarzler C, Gunthert U: CD44 isoforms during differentiation and development. Bioessays 17: 17-24, 1995

    Google Scholar 

  4. Haynes BF, Liao HX, Patton KL: The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3: 347-350, 1991

    Google Scholar 

  5. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89: 12160-12164, 1992

    Google Scholar 

  6. Mayer B, Jauch KW, Gunthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP: De-novo expression of CD44 and survival in gastric cancer. Lancet 342: 1019-1022, 1993

    Google Scholar 

  7. Miwa T, Watanabe A, Yamada Y, Shino Y, Yamada T, Yamashita J, Matsuda M, Nakano H: Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript. Cancer 77: 25-29, 1996

    Google Scholar 

  8. Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJ, Pals ST: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344: 1470-1472, 1994

    Google Scholar 

  9. Yamaguchi A, Urano T, Goi T, Saito M, Takeuchi K, Hirose K, Nakagawara G, Shiku H, Furukawa K: Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 14: 1122-1127, 1996

    Google Scholar 

  10. Kainz C, Kohlberger P, Tempfer C, Sliutz G, Gitsch G, Reinthaller A, Breitenecker G: Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer 31A: 1706-1709, 1995

    Google Scholar 

  11. Terpe HJ, Storkel S, Zimmer U, Anquez V, Fischer C, Pantel K, Gunthert U: Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol 148: 453-463, 1996

    Google Scholar 

  12. Stauder R, Eisterer W, Thaler J, Gunthert U: CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 85: 2885-2899, 1995

    Google Scholar 

  13. Tempfer C, Losch A, Heinzl H, Hausler G, Hanzal E, Kolbl H, Breitenecker G, Kainz C: Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 32A: 2023-2025, 1996

    Google Scholar 

  14. Favrot MC, Combaret V, Lasset C: CD44-a new prognostic marker for neuroblastoma. N Engl J Med 329: 1965, 1993

    Google Scholar 

  15. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P: CD44 isoforms in prognosis of breast cancer. Lancet 346: 502, 1995

    Google Scholar 

  16. Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, Beck D, Favrot MC: Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 14: 25-34, 1996

    Google Scholar 

  17. Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H: Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471-477, 1995

    Google Scholar 

  18. Iida N, Bourguignon LY: Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis. J Cell Physiol 171: 152-160, 1997

    Google Scholar 

  19. Guriec N, Marcellin L, Gairard B, Calderoli H, Wilk A, Renaud R, Bergerat JP, Oberling F: CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma. Clin Exp Metastasis 14: 434-439, 1996

    Google Scholar 

  20. Bankfalvi A, Terpe HJ, Breukelmann D, Bier B, Rempe D, Pschadka G, Krech R, Bocker W: Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology 33: 107-116, 1998

    Google Scholar 

  21. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S: Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 143: 867-874, 1993

    Google Scholar 

  22. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058, 1992

    Google Scholar 

  23. Hole AK, Belkhiri A, Snell LS, Watson PH: CD44 variant expression and estrogen receptor status in breast cancer. Breast Cancer Res Treat 43: 165-173, 1997

    Google Scholar 

  24. Combaret V, Gross N, Lasset C, Frappaz D, Beretta-Brognara C, Philip T, Beck D, Favrot MC: Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma. Eur J Cancer 33: 2101-2105, 1997

    Google Scholar 

  25. Friedrichs K, Franke F, Lisboa BW, Kugler G, Gille I, Terpe HJ, Holzel F, Maass H, Gunthert U: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55: 5424-5433, 1995

    Google Scholar 

  26. Dellas A, Schultheiss E, Almendral AC, Torhost J, Gudat F: Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia. Gynecol Oncol 62: 218-225, 1996

    Google Scholar 

  27. Ibrahim EM, Blackett AD, Tidy JA, Wells M: CD44 is a marker of endocervical neoplasia. Int J Gynecol Pathol 18: 101-108, 1999

    Google Scholar 

  28. Martegani MP, Del Prete F, Gasbarri A, Natali PG, Bartolazzi A: Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products. Am J Pathol 154: 291-300, 1999

    Google Scholar 

  29. Saegusa M, Hashimura M, Machida D, Okayasu I: Downregulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours. J Pathol 187: 173-183, 1999

    Google Scholar 

  30. Regauer S, Ott A, Berghold A, Beham A: CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage? J Pathol 187: 184-190, 1999

    Google Scholar 

  31. Beham-Schmid C, Heider KH, Hoefler G, Zatloukal K: Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse. J Pathol 186: 383-389, 1998

    Google Scholar 

  32. Nesland JM, Grude TH, Ottestad L, Johannessen JV: Invasive lobular carcinoma of the breast. The importance of an alveolar growth pattern. Pathol Annu 27 Pt 1: 233-247, 1992

    Google Scholar 

  33. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619, 1995

    Google Scholar 

  34. Jansen RH, Joosten-Achjanie SR, Arends JW, Volovics A, Hupperets PS, Schouten HC, Hillen HF: CD44v6 is not a prognostic factor in primary breast cancer. Ann Oncol 9: 109-111, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo, Norway

    Heidi S. Berner & Jahn M. Nesland

Authors
  1. Heidi S. Berner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jahn M. Nesland
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berner, H.S., Nesland, J.M. Expression of CD44 Isoforms in Infiltrating Lobular Carcinoma of the Breast. Breast Cancer Res Treat 65, 23–29 (2001). https://doi.org/10.1023/A:1006417412046

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006417412046

Search

Navigation